LobbyingScholar Rock lobbying by quarter
Scholar Rock SRRK's latest lobbying report covers Q2 2026, at under $5,000. The four quarters Q4 2025–Q3 2026 total $200K. Its first report covers Q4 2025; the issues it reports most are Medical/Disease Research/Clinical Labs.
Scholar RockSRRK
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $200K
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2025 | $200K | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medical research and clinical labs$200K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Food & Drug Administration (FDA)2 reports
- Health & Human Services, Dept of (HHS)2 reports
- HOUSE OF REPRESENTATIVES2 reports
- SENATE2 reports
Firms it paid
| Firm | ||
|---|---|---|
| H.A. Cumber & Company | $200K | 3 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| HUSEIN CUMBER | Assistant to the Secretary, USDOT; Deputy Chief of Staff, USDOT | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | H.A. Cumber & Company | Under $5,000 |
| 05/05for Q1 | H.A. Cumber & Company | Under $5,000 |
| 01/20for Q4 2025 | H.A. Cumber & Company | $200K |
| 01/20for Q4 2025 | H.A. Cumber & Company | Under $5,000 |